Search

Stories, the companies and people Loro tracks, and the primary records behind them — filings, donations, contracts and disclosures.

Company or person1

NewAmsterdam Pharma Co N.V.

Company

10 records in the corpus

Primary record10

NewAmsterdam Pharma Co N.V. filed 8-K

Item 2.02 Results of Operations and Financial Condition. On November 4, 2026, NewAmsterdam Pharma Company N.V. (the “Company”) issued a press release announcing corporate updates and its financial results for the quarter

04 Nov 2026 · sec daily index

NewAmsterdam Pharma Co N.V. filed 4

SEC form 4 filed by NewAmsterdam Pharma Co N.V. (CIK 1936258) on 2026-10-02.

02 Oct 2026 · sec daily index

NewAmsterdam Pharma Co N.V. filed 8-K

Item 8.01 Other Events. On September 29, 2026, NewAmsterdam Pharma Company N.V. (the Company ) announced the dosing of the first patient in SPINOZA, a Phase 2b clinical trial evaluating obicetrapib in individuals with pr

29 Sep 2026 · sec daily index

NewAmsterdam Pharma Co N.V. filed SCHEDULE 13D/A

0001231919-26-001215.txt : 20260922 SCHEDULE 13D/A 1 primary_doc.xml X0202 SCHEDULE 13D/A 0001790879 XXXXXXXX LIVE 7 Ordinary Shares, nominal value EUR0.12 per share 09/18/2026 false 0001936258 N62509109 NEWAMSTERDAM PHA

22 Sep 2026 · sec daily index

NewAmsterdam Pharma Co N.V. filed 8-K

Item 8.01 Other Events. On September 21, 2026, NewAmsterdam Pharma Company N.V. (the Company ) along with its partner Menarini Group ( Menarini ) announced that the European Commission ( EC ) has granted marketing author

21 Sep 2026 · sec daily index

NewAmsterdam Pharma Co N.V. filed 4

SEC form 4 filed by NewAmsterdam Pharma Co N.V. (CIK 1936258) on 2026-09-15.

15 Sep 2026 · sec daily index

NewAmsterdam Pharma Co N.V. filed 4

SEC form 4 filed by NewAmsterdam Pharma Co N.V. (CIK 1936258) on 2026-09-09.

09 Sep 2026 · sec daily index

NewAmsterdam Pharma Co N.V. filed 4

SEC form 4 filed by NewAmsterdam Pharma Co N.V. (CIK 1936258) on 2026-09-03.

03 Sep 2026 · sec daily index

NewAmsterdam Pharma Co N.V. filed 4

SEC form 4 filed by NewAmsterdam Pharma Co N.V. (CIK 1936258) on 2026-08-25.

25 Aug 2026 · sec daily index

NewAmsterdam Pharma Co N.V. filed 8-K

Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. On August 10, 2026, NewAmsterdam Pharma Company N.V. (the “Comp

14 Aug 2026 · sec daily index